Alex Cooper is baring it all.In a new Hulu docuseries, aptly titled Call Her Alex, the Cal...
Moscow has committed itself to not deploying intermediate-range rockets unless Washington...
There aren't many comic book characters as universally popular as Marvel's notoriously fou...
Tehran indicates it will not accept the US proposal made during the fifth round of talks l...
Chappell Roanmay be one of the biggest pop stars in the world right now, but she's not afr...
Countries
Opinion
It’s ‘a small part of LA’ is latest media refrain to minimize violent mobs
Karnataka Seeks National Highway Welcome Arch, Investigates Local Incidents
Voices: Why are the British courts handing a propaganda win to the Myanmar junta?
-
PR Newswire ( Middle East ) 2025/6/3Highly experienced biopharma executive Dr Cristina Csimma joins Asgard's Board of Directors, while esteemed immunologists Prof Ignacio Meler...
- PR Newswire ( Middle East ) 2025/6/1
SAN FRANCISCO and SUZHOU, China, June 1, 2025 /PRNewswire/ -- Innovent Biologics, Inc (Suzhou) (HKEX: 01801), a world-class biopharmaceutica...
-
Independent ( Yemen ) 2025/5/31A new study found the drug kept head and neck cancers at bay for five years compared to 30 months with standard care
-
PR Newswire ( Middle East ) 2025/5/15Dark genome biotech RyboDyn deepens partnership with world-leading cancer immunotherapy center to validate novel oncology targets and advanc...
-
Medscape ( Middle East ) 2025/5/5Patients who were most likely to discontinue therapy had allergy to milk, sesame, and egg — all of which were associated with higher severe...
-
PR Newswire ( Middle East ) 2025/5/2KING OF PRUSSIA, Pa., May 1, 2025 /PRNewswire/ -- SK Life Science Labs, a subsidiary of SK Biopharmaceuticals Co., Ltd., a global biotech fo...
-
Medscape ( Middle East ) 2025/4/30Neoadjuvant PD-1 blockade in early-stage mismatch repair–deficient solid rectal and non-rectal tumors can eliminate the need for surgery in...
-
PRESSBEE ( Middle East ) 2025/4/29Immunotherapy represents a significant advancement in the treatment of cancer, providing patients with less invasive options compared to tra...
- Medscape ( Middle East ) 2025/4/25
Treatment shows improved quality-of-life measures and significant immunological changes. Medscape Medical News
- Medscape ( Middle East ) 2025/4/23
NICE has approved nivolumab plus ipilimumab for NHS use in patients with aggressive colorectal cancer, following new evidence of clinical be...
- Medscape ( Middle East ) 2025/4/2
Real world data show that immunotherapy leads to better overall survival outcomes than chemotherapy in patients with microsatellite instable...
- Medscape ( Middle East ) 2025/3/26
Neoadjuvant chemoimmunotherapy is associated with significantly improved survival outcomes compared with standard chemoradiotherapy in patie...
- PR Newswire ( Middle East ) 2025/3/15
GAINESVILLE, Fla, March 14, 2025 /PRNewswire/ -- iOncologi, Inc., a clinical-stage biopharmaceutical company focused on advancing immunother...
- Medscape ( Middle East ) 2025/3/12
Chronic cutaneous adverse events affected 8% of patients after checkpoint inhibitor therapy in a cohort study, often persisting for years....
- Medscape ( Middle East ) 2025/3/12
OUtMATCH 2 and 3: In the trials, omalizumab and multi-allergen oral immunotherapy showed alike efficacy in protecting against food allergies...
